| Dr Kristina Joy Rauenhorst, MD | |
|
300 State Avenue, Faribault, MN 55021 | |
| (507) 330-0078 | |
| (507) 333-3214 |
| Full Name | Dr Kristina Joy Rauenhorst |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 300 State Avenue, Faribault, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508992629 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 19443 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System - Mankato | Mankato, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic Health System-southeast Minnesota Region | 4385556703 | 573 |
News Archive
Recent government expenditures to improve access to effective health care in Delhi, India, have been insufficient to overcome the impact of poverty and inequalities, leading to a rise in deaths from preventable illness such as septicemia and tuberculosis in the capital city, according to a study led by Rutgers School of Public Health researcher Michael K. Gusmano.
UNISON today welcomed new Treasury guidance aimed at putting social issues at the heart of public procurement.
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.
The Tielayer is a new ultra-thin thermoplastic coating that can transform the medical device industry.
Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southeast Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891701637 PECOS PAC ID: 4385556703 Enrollment ID: O20031104000408 |
News Archive
Recent government expenditures to improve access to effective health care in Delhi, India, have been insufficient to overcome the impact of poverty and inequalities, leading to a rise in deaths from preventable illness such as septicemia and tuberculosis in the capital city, according to a study led by Rutgers School of Public Health researcher Michael K. Gusmano.
UNISON today welcomed new Treasury guidance aimed at putting social issues at the heart of public procurement.
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.
The Tielayer is a new ultra-thin thermoplastic coating that can transform the medical device industry.
Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545422 PECOS PAC ID: 4688585771 Enrollment ID: O20031110000134 |
News Archive
Recent government expenditures to improve access to effective health care in Delhi, India, have been insufficient to overcome the impact of poverty and inequalities, leading to a rise in deaths from preventable illness such as septicemia and tuberculosis in the capital city, according to a study led by Rutgers School of Public Health researcher Michael K. Gusmano.
UNISON today welcomed new Treasury guidance aimed at putting social issues at the heart of public procurement.
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.
The Tielayer is a new ultra-thin thermoplastic coating that can transform the medical device industry.
Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.
› Verified 5 days ago
| Entity Name | Mayo Clinic Health System-southwest Minnesota Region |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1124035282 PECOS PAC ID: 4688585771 Enrollment ID: O20171011003939 |
News Archive
Recent government expenditures to improve access to effective health care in Delhi, India, have been insufficient to overcome the impact of poverty and inequalities, leading to a rise in deaths from preventable illness such as septicemia and tuberculosis in the capital city, according to a study led by Rutgers School of Public Health researcher Michael K. Gusmano.
UNISON today welcomed new Treasury guidance aimed at putting social issues at the heart of public procurement.
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.
The Tielayer is a new ultra-thin thermoplastic coating that can transform the medical device industry.
Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristina Joy Rauenhorst, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (651) 267-5000 | Dr Kristina Joy Rauenhorst, MD 300 State Avenue, Faribault, MN 55021 Ph: (507) 330-0078 |
News Archive
Recent government expenditures to improve access to effective health care in Delhi, India, have been insufficient to overcome the impact of poverty and inequalities, leading to a rise in deaths from preventable illness such as septicemia and tuberculosis in the capital city, according to a study led by Rutgers School of Public Health researcher Michael K. Gusmano.
UNISON today welcomed new Treasury guidance aimed at putting social issues at the heart of public procurement.
Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.
The Tielayer is a new ultra-thin thermoplastic coating that can transform the medical device industry.
Patients with earlier stage high-risk Chronic Lymphocytic Leukemia recently began receiving a new combination treatment in a Phase I/II clinical trial that researchers believe could result in a more effective therapy for this disease, Biothera announced today.
› Verified 5 days ago
Jory M Burroughs, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 300 State Ave, Faribault, MN 55021 Phone: 507-333-3300 | |
Brant Dennis Barr, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 924 1st St Ne, Faribault, MN 55021 Phone: 507-333-3300 Fax: 507-333-3214 | |
Michael Seryakov, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 635 1st St Se, Faribault, MN 55021 Phone: 507-333-3300 | |
Thomas George Howell Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 924 1st St Ne, Faribault, MN 55021 Phone: 507-333-3300 Fax: 507-333-3214 |